Location: Stockholm, Sweden
CIK: 0001599882 · Show all filings
Period: Q2 2016 (← Previous) (Next →)
Filing Date: Aug 1, 2016
Total Value: $563M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Alexion Pharmaceuticals Inc | 223,082 | $26.05M | 4.6% | $140.26 | — | COM | 015351109 |
| GILD | Gilead Sciences Inc | 240,000 | $20.02M | 3.6% | $64.31 | -2.4% | COM | 375558103 |
| — | Celgene Corp | 199,000 | $19.63M | 3.5% | $106.40 | — | COM | 151020104 |
| BIIB | Biogen Inc | 80,000 | $19.35M | 3.4% | $263.83 | -0.1% | COM | 09062X103 |
| LLY | Eli Lilly & Co | 235,000 | $18.51M | 3.3% | $59.62 | +7.5% | COM | 532457108 |
| REGN | Regeneron Pharmaceuticals Inc | 49,500 | $17.29M | 3.1% | $381.83 | +0.3% | COM | 75886F107 |
| INCY | Incyte Corp Ltd | 170,000 | $13.6M | 2.4% | $71.96 | +7.9% | COM | 45337C102 |
| PFE | Pfizer Inc | 375,000 | $13.2M | 2.3% | $20.45 | +3.0% | COM | 717081103 |
| — | Cigna Corp | 99,000 | $12.67M | 2.3% | $132.89 | — | COM | 125509109 |
| — | Allergan Plc | 52,000 | $12.02M | 2.1% | $288.88 | — | SHS | G0177J108 |
| UNH | United Health Group Inc | 85,000 | $12M | 2.1% | $96.51 | +18.3% | COM | 91324P102 |
| BMRN | BioMarin Pharmaceutical Inc | 150,000 | $11.67M | 2.1% | $86.90 | -2.2% | COM | 09061G101 |
| CVS | CVS Health Corp | 120,000 | $11.49M | 2.0% | $68.57 | +8.7% | COM | 126650100 |
| — | Abiomed Inc | 105,000 | $11.47M | 2.0% | $74.57 | — | COM | 003654100 |
| MDT | Medtronic Plc | 127,000 | $11.02M | 2.0% | $58.05 | +9.4% | SHS | G5960L103 |
| ALNY | Alnylam Pharmaceuticals Inc | 195,000 | $10.82M | 1.9% | $75.18 | -16.2% | COM | 02043Q107 |
| BMY | Bristol Myers Squibb Co | 137,000 | $10.08M | 1.8% | $39.46 | +28.0% | COM | 110122108 |
| — | Endo International Plc | 635,200 | $9.903M | 1.8% | $29.08 | — | SHS | G30401106 |
| JAZZ | Jazz Pharmaceuticals Plc | 70,000 | $9.892M | 1.8% | $157.17 | -6.2% | SHS | G50871105 |
| AMGN | Amgen Inc | 61,500 | $9.357M | 1.7% | $113.59 | +2.7% | COM | 031162100 |
| — | Express Scripts Hg Co | 116,000 | $8.793M | 1.6% | $81.32 | — | COM | 30219G108 |
| ZBH | Zimmer Biomet Hgs Inc | 71,000 | $8.547M | 1.5% | $91.33 | +14.5% | COM | 98956P102 |
| — | Aetna Inc | 67,000 | $8.183M | 1.5% | $104.69 | — | COM | 00817Y108 |
| — | Cepheid Inc | 260,000 | $7.995M | 1.4% | $35.42 | — | COM | 15670R107 |
| CNC | Centene Corp | 111,712 | $7.973M | 1.4% | $30.22 | +3.9% | COM | 15135B101 |
| HCA | HCA Holdings Inc | 100,000 | $7.701M | 1.4% | $70.94 | +3.4% | COM | 40412C101 |
| EW | Edwards Lifesciences Corp | 70,000 | $6.981M | 1.2% | $23.73 | +44.2% | COM | 28176E108 |
| — | Nektar Therapeutics | 470,000 | $6.688M | 1.2% | $11.22 | — | COM | 640268108 |
| CAH | Cardinal Health Inc | 82,000 | $6.397M | 1.1% | $60.16 | +0.2% | COM | 14149Y108 |
| EXEL | Exelixis Inc | 800,000 | $6.248M | 1.1% | $5.30 | +8.7% | COM | 30161Q104 |
| HOLX | Hologic Inc | 180,000 | $6.228M | 1.1% | $32.75 | +5.7% | COM | 436440101 |
| COR | AmerisourceBergen Corp | 78,000 | $6.187M | 1.1% | $62.62 | -4.4% | COM | 03073E105 |
| — | Horizon Pharma Plc | 370,000 | $6.094M | 1.1% | $18.54 | — | SHS | G4617B105 |
| — | Laboratory Corp of America Hgs | 45,000 | $5.862M | 1.0% | $121.84 | — | COM | 50540R409 |
| ALKS | Alkermes Plc | 135,599 | $5.861M | 1.0% | $45.76 | -9.8% | SHS | G01767105 |
| MD | Mednax Inc | 80,000 | $5.794M | 1.0% | $68.74 | 0.0% | COM | 58502B106 |
| SUPN | Supernus Pharmaceuticals Inc | 280,000 | $5.704M | 1.0% | $8.66 | +104.8% | COM | 868459108 |
| MCK | McKesson Corp | 30,000 | $5.6M | 1.0% | $191.15 | -14.9% | COM | 58155Q103 |
| — | Walgreens Boots Alliance Inc | 65,300 | $5.438M | 1.0% | $85.15 | — | COM | 931427108 |
| — | Endologix Inc | 435,000 | $5.42M | 1.0% | $12.10 | — | COM | 29266S106 |
| HUM | Humana Inc | 30,000 | $5.396M | 1.0% | $169.43 | -3.1% | COM | 444859102 |
| — | Lion Biotechnologies Inc | 650,000 | $5.265M | 0.9% | $8.37 | — | COM | 53619R102 |
| ELV | Anthem Inc | 40,000 | $5.254M | 0.9% | $134.01 | -10.5% | COM | 036752103 |
| VRTX | Vertex Pharmaceuticals Inc | 60,000 | $5.161M | 0.9% | $102.25 | -15.5% | COM | 92532F100 |
| — | Medivation Inc | 80,000 | $4.824M | 0.9% | $53.83 | — | COM | 58501N101 |
| — | Cerner Corp | 81,000 | $4.747M | 0.8% | $61.66 | — | COM | 156782104 |
| — | Ariad Pharmaceuticals Inc | 625,000 | $4.619M | 0.8% | $6.70 | — | COM | 04033A100 |
| — | Intra-Cellular Therapies Inc | 115,000 | $4.464M | 0.8% | $19.23 | — | COM | 46116X101 |
| OMCL | Omnicell Inc | 128,537 | $4.4M | 0.8% | $31.17 | +0.0% | COM | 68213N109 |
| — | ZELTIQ Aesthetics Inc | 160,000 | $4.373M | 0.8% | $29.38 | — | COM | 98933Q108 |
| DXCM | Dexcom Inc | 55,000 | $4.363M | 0.8% | $12.76 | +33.4% | COM | 252131107 |
| ABBV | AbbVie Inc | 70,000 | $4.334M | 0.8% | $37.54 | +9.1% | COM | 00287Y109 |
| — | Cooper Companies Inc (The) | 25,000 | $4.289M | 0.8% | $171.80 | — | COM | 216648402 |
| XNCR | Xencor Inc | 225,000 | $4.273M | 0.8% | $14.34 | -4.4% | COM | 98401F105 |
| — | Valeant Pharm Intl Inc | 210,000 | $4.229M | 0.8% | $39.55 | — | COM | 91911K102 |
| — | Nevro Corp | 54,300 | $4.005M | 0.7% | $67.31 | — | COM | 64157F103 |
| MGNX | Macrogenics Inc | 140,000 | $3.779M | 0.7% | $25.02 | -9.9% | COM | 556099109 |
| — | Radius Health Inc | 100,000 | $3.675M | 0.7% | $31.44 | — | COM | 750469207 |
| LIVN | Livanova Plc | 70,000 | $3.516M | 0.6% | $60.40 | -16.3% | SHS | G5509L101 |
| — | Kite Pharma Inc | 70,000 | $3.5M | 0.6% | $50.00 | — | COM | 49803L109 |
| ABT | Abbott Laboratories | 84,100 | $3.306M | 0.6% | $33.35 | 0.0% | COM | 002824100 |
| — | NxStage Medical Inc | 145,300 | $3.15M | 0.6% | $21.68 | — | COM | 67072V103 |
| — | Revance Therapeutics Inc | 220,000 | $2.992M | 0.5% | $23.00 | — | COM | 761330109 |
| — | Keryx Biopharmaceuticals Inc | 450,111 | $2.98M | 0.5% | $6.26 | — | COM | 492515101 |
| — | Cempra Inc | 171,000 | $2.82M | 0.5% | $33.87 | — | COM | 15130J109 |
| BDX | Becton Dickinson & Co | 15,000 | $2.544M | 0.5% | $118.02 | +17.2% | COM | 075887109 |
| PODD | Insulet Corp | 82,000 | $2.48M | 0.4% | $34.93 | -10.9% | COM | 45784P101 |
| — | Portola Pharmaceuticals Inc | 105,000 | $2.478M | 0.4% | $35.25 | — | COM | 737010108 |
| — | NeuroDerm Ltd | 144,546 | $2.349M | 0.4% | $16.25 | — | SHS | M74231107 |
| CHRS | Coherus BioSciences Inc | 131,357 | $2.219M | 0.4% | $18.77 | 0.0% | COM | 19249H103 |
| — | Dynavax Technologies Corp | 150,000 | $2.187M | 0.4% | $20.77 | — | COM | 268158201 |
| — | Chimerix Inc | 550,000 | $2.162M | 0.4% | $10.40 | — | COM | 16934W106 |
| HALO | Halozyme Therapeutics Inc | 250,000 | $2.158M | 0.4% | $16.27 | -39.4% | COM | 40637H109 |
| CYH | Community Health Syst Inc | 175,000 | $2.109M | 0.4% | $26.36 | -44.4% | COM | 203668108 |
| — | Achillion Pharmaceuticals Inc | 266,000 | $2.075M | 0.4% | $9.71 | — | COM | 00448Q201 |
| — | Adamas Pharmaceuticals Inc | 130,000 | $1.968M | 0.3% | $15.14 | — | COM | 00548A106 |
| — | Rigel Pharmaceuticals Inc | 850,000 | $1.896M | 0.3% | $3.57 | — | COM | 766559603 |
| — | FibroGen Inc | 114,000 | $1.871M | 0.3% | $25.32 | — | COM | 31572Q808 |
| NBIX | Neurocrine Biosciences Inc | 40,000 | $1.818M | 0.3% | $39.68 | +16.0% | COM | 64125C109 |
| PRGO | Perrigo Co Plc | 20,000 | $1.813M | 0.3% | $165.12 | -37.3% | SHS | G97822103 |
| ACAD | Acadia Pharmaceuticals Inc | 50,000 | $1.623M | 0.3% | $25.97 | +28.9% | COM | 004225108 |
| — | Tandem Diabetes Care Inc | 209,000 | $1.576M | 0.3% | $12.69 | — | COM | 875372104 |
| ESPR | Esperion Therapeutics Inc | 140,000 | $1.383M | 0.2% | $20.34 | -18.5% | COM | 29664W105 |
| — | Array BioPharma Inc | 370,000 | $1.317M | 0.2% | $4.79 | — | COM | 04269X105 |
| — | Tetraphase Pharmaceuticals Inc | 300,000 | $1.29M | 0.2% | $17.20 | — | COM | 88165N105 |
| — | Catabasis Pharmaceuticals Inc | 345,100 | $1.277M | 0.2% | $10.91 | — | COM | 14875P107 |
| — | Regulus Therapeutic Inc | 350,000 | $1.012M | 0.2% | $4.98 | — | COM | 75915K101 |
| — | Anthera Pharmaceuticals Inc | 300,000 | $927K | 0.2% | $3.60 | — | COM | 03674U201 |
| — | Quorum Health Corp | 56,250 | $602K | 0.1% | $10.70 | — | COM | 74909E106 |
| — | Orexigen Therapeutics Inc | 1,200,000 | $516K | 0.1% | $5.13 | — | COM | 686164104 |
| RARE | Ultragenyx Pharmaceutical Inc | 10,000 | $489K | 0.1% | $65.43 | -1.1% | COM | 90400D108 |
| — | Adverum Biotechnologies Inc | 154,006 | $487K | 0.1% | $3.16 | — | COM | 00773U108 |
| — | Concert Pharm Inc | 30,099 | $338K | 0.1% | $11.23 | — | COM | 206022105 |
| — | Mirati Therapeutics Inc | 50,000 | $273K | 0.0% | $31.48 | — | COM | 60468T105 |
| OCUL | Ocular Therapeutix Inc | 40,000 | $198K | 0.0% | $7.57 | +30.8% | COM | 67576A100 |
| GKOS | Glaukos Corp | 5,100 | $149K | 0.0% | $23.15 | 0.0% | COM | 377322102 |
| — | Threshold Pharmaceuticals | 201,537 | $128K | 0.0% | $4.08 | — | COM | 885807206 |